The role of levodopa in the management of dementia with Lewy bodies

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2005-08-16

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/jnnp.2004.052332PMID 16107351PMCID PMC1739807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• l-Dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia

  2004cited by this paper
• Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?

  2004cited by this paper
• Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study

  2003cited by this paper
• Accuracy of acute levodopa challenge for clinical prediction of sustained long‐term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis

  2002cited by this paper
• Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine.

  2002cited by this paper
• Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors.

  2002cited by this paper
• Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

  2002cited by this paper
• Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

  2002cited by this paper
• Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease

  2000cited by this paper
• Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

  1999cited by this paper
• Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD)

  1999cited by this paper
• Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients

  1998cited by this paper
• Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.

  1997cited by this paper
• Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse lewy body disease and 34 pathologically confirmed cases of parkinson's disease

  1997cited by this paper
• The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies

  1997cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease

  1995cited by this paper
• Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• The prevalence of dementia in a total population: a comparison of two screening instruments.

  1991cited by this paper
• Diffuse Lewy body disease: clinical features in 15 cases.

  1989cited by this paper
• Cortical Lewy body dementia: clinical features and classification.

  1989cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Compensatory hallucinogenesis across three neuropsychiatric disorders: a Bayesian account

  2026cites this paper
• Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

  2025cites this paper
• Early Motor Signs in Pathologically Verified Alzheimer's Disease and Lewy Body Disease

  2025cites this paper
• Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?

  2025cites this paper
• The evolving therapeutic landscape of dementia with Lewy bodies.

  2025cites this paper
• [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

  2025cites this paper
• Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology

  2025cites this paper
• Comparison of Quantitative-Electroencephalogram (q-EEG) Measurements Between Patients of Dementia with Lewy Bodies (DLB) and Parkinson Disease Dementia (PDD)

  2025cites this paper
• Kidney Impairment and α-Synucleinopathy: Implications for Assessment and Treatment

  2025cites this paper
• Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Pharmacological strategies for managing dementia with Lewy bodies: an expert review of symptom-targeted care

  2025cites this paper
• Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning

  2025cites this paper
• A model for de novo pigmentation of amelanotic retinal pigment epithelial cells

  2025cites this paper
• On Levodopa Interactions with Brain Disease Amyloidogenic Proteins at the Nanoscale

  2025cites this paper
• Type‐Specific Single‐Neuron Analysis Reveals Mitochondrial DNA Maintenance Failure Affecting Atrophying Pontine Neurons Differentially in Lewy Body Dementia Syndromes

  2025cites this paper
• Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkisnsonism

  2024cites this paper
• Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies

  2024cites this paper
• Insights into the management of Lewy body dementia: a scoping review

  2024cites this paper
• A rare case of early onset lewy body dementia with parkinsonism associated with chronic exposure to copper contaminated drinking water

  2024cites this paper
• Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study

  2023influential citation
• Systematic review of pharmacological interventions for people with Lewy body dementia

  2022cites this paper
• Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update

  2022cites this paper
• Chemical composition, antibacterial and antioxidant activities of acetone extract from the branches and leaves of Jasminum annamense subsp. annamense (Oleaceae)

  2022cites this paper
• Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

  2022cites this paper
• Morphological classification and changes in dementia (Review).

  2021cites this paper
• Psychosocial support for people with dementia with Lewy bodies

  2021cites this paper
• Outcome Measures for Dementia With Lewy Body Clinical Trials

  2021cites this paper
• Invited Perspective on the "Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial".

  2021cites this paper
• Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients

  2021cites this paper
• THE ENIGMA OF LEWY BODY DEMENTIA: A CASE REPORT

  2020cites this paper
• Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials

  2020cites this paper
• Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism

  2020cites this paper
• Dementia With Lewy Bodies

  2020cites this paper
• Prognosis and treatment of dementia with Lewy bodies

  2020cites this paper
• Dementia with Lewy bodies - a clinicopathological update.

  2020cites this paper
• New evidence on the management of Lewy body dementia.

  2020cites this paper
• Lewy Body Disease

  2019cites this paper
• Vortioxetine and Lewy Body Disorders

  2019cites this paper
• The dysfunctional brain dynamic of Lewy body dementia and its behavioural and clinical correlates : an fMRI and EEG analysis

  2019cites this paper
• Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: A phase 3 randomized clinical trial.

  2019cites this paper
• Clinical drug development for dementia with Lewy bodies: past and present

  2019cites this paper
• Donepezil and α-synuclein Constipation: A 48 Month Follow-Up

  2019cites this paper
• Dementia with Lewy Bodies

  2019cites this paper
• Parkinson's Disease Dementia and Lewy Body Disease

  2019cites this paper
• Major or Mild Neurocognitive Disorders with Lewy Bodies

  2018cites this paper
• Living with Lewy body dementia. Treatment, survival & quality of life.

  2018cites this paper
• Lewy Body Dementia.

  2018cites this paper
• Available and future treatments for atypical parkinsonism. A systematic review

  2018cites this paper
• Donepezil for α‐synuclein Constipation: An 18 Month Follow-Up

  2018cites this paper
• Advances in the pharmacotherapeutic management of dementia with Lewy bodies

  2018cites this paper
• A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment

  2018cites this paper
• Prevalence and Treatment of Constipation in Patients with Alpha-Synuclein Pathology

  2018cites this paper
• Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies

  2018cites this paper
• REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)

  2018cites this paper
• Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles

  2018cites this paper
• Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

  2018cites this paper
• Zonisamide for DLB parkinsonism

  2018cites this paper
• Donepezil for Constipation in Lewy Body Diseases: Four Case Studies

  2017cites this paper
• NON-AD DEMENTIAS: ALPHA-SYNUCLEINOPATHIES

  2017cites this paper
• Diagnosis and management of dementia with Lewy bodies

  2017cites this paper
• Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort

  2017cites this paper
• Can deep brain stimulation of the nucleus basalis of Meynert improve thinking and memory problems in Lewy body dementias

  2017cites this paper
• A Multiple Domain Collaborative Care Model for Independent Practice Psychologists Working With Older Adults

  2017cites this paper
• Lewy body dementia

  2017cites this paper
• The Lewy Body Dementias: Dementia with Lewy Bodies and Related Syndromes

  2017cites this paper
• Lewy Body Disorders.

  2017cites this paper
• Galasko 326 THE WHAT AND WHERE OF DEMENTIA WITH LEWY BODIES PATHOLOGY

  2017cites this paper
• Paciente con alucinaciones y deterioro cognitivo: posibles diagnósticos diferenciales que deben considerarse

  2016cites this paper
• Clinical course and prognosis in patients with Gaucher disease and parkinsonism

  2016cites this paper
• Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

  2016cites this paper
• Biomarkers in dementia with Lewy bodies

  2016cites this paper
• Medications linked to cognitive impairment in older adults.

  2016cites this paper
• Neurocognitive disorder with Lewy bodies: Evidence-based diagnosis and treatment.

  2016cites this paper
• Dementia With Lew Body

  2016cites this paper
• Dementia with Lewy bodies — an Investigation of Cause and Consequence

  2016cites this paper
• Revista Española de Geriatría y Gerontología

  2016cites this paper
• Parkinson Disease and Dementia

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Characterisation of Sirtuins in Parkinson's disease

  2016cites this paper
• Clinical Response of Levodopa Carbidopa Combination in Patients with Idiopathic Parkinsonism.

  2016cites this paper
• Visual search in Dementia with Lewy Bodies and Alzheimer's disease.

  2015cites this paper
• Comprehensive treatment of dementia with Lewy bodies

  2015cites this paper
• Parkinson's disease dementia and dementia with lewy bodies.

  2015cites this paper
• Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

  2015cites this paper
• Phenotypic and metabolic imaging characterization of posterior cognitive dysfunctions.

  2015cites this paper
• Dementia with Lewy Bodies

  2014cites this paper
• Treatment of Parkinsonism in Patients with Non-Parkinson Dementia

  2014cites this paper
• Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review

  2014cites this paper
• Tesis doctoral UTILIDAD DE LA GAMMAGRAFÍA DE INERVACIÓN MIOCÁRDICA CON 123I-MIBG EN EL DIAGNÓSTICO CLÍNICO DE LA DEMENCIA DE CUERPOS DE LEWY

  2014cites this paper
• Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism

  2014cites this paper
• Biomarkers in biological fluids for dementia with

  2014cites this paper
• Maladie à corps de Lewy

  2014cites this paper
• The spectrum of cognitive impairment in Lewy body diseases

  2014influential citation
• Biomarkers in biological fluids for dementia with Lewy bodies

  2014cites this paper
• Clinical features of dementia with lewy bodies in 35 Chinese patients

  2014cites this paper
• Malattia a corpi di Lewy

  2014cites this paper
• Can we clinically diagnose dementia with Lewy bodies yet?

  2013cites this paper
• Evaluation and management of oropharyngeal dysphagia in different types of dementia: a systematic review.

  2013cites this paper
• Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.

  2013cites this paper
• Dementia with Lewy Bodies

  2013cites this paper